EUVIMEDEUVIMED entdecken
Open Access

Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson’s Disease without Dementia

Lauren G Santos iD, Lauren E Kenney, Alyssa Ray, Alfredo Paredes, Adrianna M Ratajska, Kara Eversole, Bhavana Patel, Ashley E Rawls, Michael S Okun, Dawn Bowers

Archives of Clinical Neuropsychology · 2024

DOI: 10.1093/arclin/acae041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Clinical Neuropsychology, 2024. Verfasst von Lauren G Santos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Health Psychology, University of Florida, PO Box 100165 Gainesville, FL 32610-0165. Hauptthemen laut MEDLINE: Parkinson Disease, Cholinergic Antagonists. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cognitive changes are heterogeneous in Parkinson’s disease (PD). This study compared whether anticholinergic burden drives differences in cognitive domain performance and empirically-derived PD-cognitive phenotypes.

Method

A retrospective chart review contained participants (n = 493) who had idiopathic PD without dementia. Participants’ medications were scored (0–3) and summed based on the anticholinergic cognitive burden scale (ACBS). We examined the ACBS’ relationship to five cognitive domain composites (normative z-scores) and three (K-means clustering based) cognitive phenotypes: cognitively intact, low executive function (EF), and predominately impaired EF/memory. Analyses included Spearman correlations, analysis of covariance, and Pearson chi-squared test.

Results

Overall, phenotypes did not differ in anticholinergic burden, and (after false-discovery-rate corrections) no cognitive domains related. When comparing those above and below the clinically relevant ACBS cutoff (i.e., score ≥3), no significant phenotype or domain differences were found.

Conclusions

Anticholinergic medication usage did not drive cognitive performance in a large clinical sample of idiopathic PD without dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseCholinergic AntagonistsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesExecutive FunctionNeuropsychological TestsCognitive DysfunctionDementiaCognitionAged, 80 and over

Stichwörter der Autor:innen

Anticholinergic burdenCognitive risk factorsParkinson’s disease

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Department of Clinical and Health Psychology, University of Florida, PO Box 100165 Gainesville, FL 32610-0165.
  • Norman Fixel Institute for Neurological Diseases, University of Florida, 3009 SW Williston Road Gainesville, FL 32608.
  • Department of Neurology, University of Florida, Box 100236 Gainesville, FL 32610-0236.

ORCID-Profile: Lauren G Santos

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Santos, L. G., Kenney, L. E., Ray, A., Paredes, A., Ratajska, A. M., Eversole, K., Patel, B., Rawls, A. E., Okun, M. S., & Bowers, D. (2024). Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson’s Disease without Dementia. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acae041

Vancouver

Santos LG, Kenney LE, Ray A, Paredes A, Ratajska AM, Eversole K, et al. Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson’s Disease without Dementia. Archives of Clinical Neuropsychology. 2024. doi:10.1093/arclin/acae041

BibTeX
@article{Santos2024,
  author = {Santos, Lauren G and Kenney, Lauren E and Ray, Alyssa and Paredes, Alfredo and Ratajska, Adrianna M and Eversole, Kara and Patel, Bhavana and Rawls, Ashley E and Okun, Michael S and Bowers, Dawn},
  title = {Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson’s Disease without Dementia},
  journal = {Archives of Clinical Neuropsychology},
  year = {2024},
  doi = {10.1093/arclin/acae041}
}
Kostenlos starten →